Cargando…
Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study
INTRODUCTION: A remarkable difference in care delivery pathways for Chronic Obstructive Pulmonary Disease (COPD) is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. The objective of this paper is to explain this difference. METHODS: Descriptive C...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Igitur, Utrecht Publishing & Archiving
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440249/ https://www.ncbi.nlm.nih.gov/pubmed/22977431 |
_version_ | 1782243129413337088 |
---|---|
author | Utens, Cecile M.A Maarse, J.A.M van Schayck, Onno C.P Maesen, Boudewijn L.P Rutten, Maureen P.M.H Smeenk, Frank W.J.M |
author_facet | Utens, Cecile M.A Maarse, J.A.M van Schayck, Onno C.P Maesen, Boudewijn L.P Rutten, Maureen P.M.H Smeenk, Frank W.J.M |
author_sort | Utens, Cecile M.A |
collection | PubMed |
description | INTRODUCTION: A remarkable difference in care delivery pathways for Chronic Obstructive Pulmonary Disease (COPD) is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. The objective of this paper is to explain this difference. METHODS: Descriptive COPD statistics and care delivery pathways on all care levels within the institutional context, followed by a comparison of care delivery pathways and an explanation of the difference with regard to hospital-at-home. RESULTS: The Netherlands and England show broad similarities in their care delivery pathways for COPD patients. A major difference is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. Three possible explanations for this difference are presented: differences in the urgency for alternatives (higher urgency for alternative treatment models in England), the differences in funding (funding in England facilitated the development of hospital-at-home) and the differences in the substitution of tasks to nurses (substitution to nurses has taken place to a larger extent in England). DISCUSSION AND CONCLUSION: The difference between the Netherlands and England regarding hospital-at-home for COPD exacerbations can be explained in three ways. Hospital-at-home has proved to be a safe alternative for hospital care for selected patients, and should be considered as a treatment option for COPD exacerbations in the Netherlands. |
format | Online Article Text |
id | pubmed-3440249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Igitur, Utrecht Publishing & Archiving |
record_format | MEDLINE/PubMed |
spelling | pubmed-34402492012-09-13 Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study Utens, Cecile M.A Maarse, J.A.M van Schayck, Onno C.P Maesen, Boudewijn L.P Rutten, Maureen P.M.H Smeenk, Frank W.J.M Int J Integr Care Policy Paper INTRODUCTION: A remarkable difference in care delivery pathways for Chronic Obstructive Pulmonary Disease (COPD) is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. The objective of this paper is to explain this difference. METHODS: Descriptive COPD statistics and care delivery pathways on all care levels within the institutional context, followed by a comparison of care delivery pathways and an explanation of the difference with regard to hospital-at-home. RESULTS: The Netherlands and England show broad similarities in their care delivery pathways for COPD patients. A major difference is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. Three possible explanations for this difference are presented: differences in the urgency for alternatives (higher urgency for alternative treatment models in England), the differences in funding (funding in England facilitated the development of hospital-at-home) and the differences in the substitution of tasks to nurses (substitution to nurses has taken place to a larger extent in England). DISCUSSION AND CONCLUSION: The difference between the Netherlands and England regarding hospital-at-home for COPD exacerbations can be explained in three ways. Hospital-at-home has proved to be a safe alternative for hospital care for selected patients, and should be considered as a treatment option for COPD exacerbations in the Netherlands. Igitur, Utrecht Publishing & Archiving 2012-05-18 /pmc/articles/PMC3440249/ /pubmed/22977431 Text en Copyright 2012, International Journal of Integrated Care (IJIC) http://creativecommons.org/licenses/by/3.0/ This work is licensed under a (http://creativecommons.org/licenses/by/3.0) Creative Commons Attribution 3.0 Unported License |
spellingShingle | Policy Paper Utens, Cecile M.A Maarse, J.A.M van Schayck, Onno C.P Maesen, Boudewijn L.P Rutten, Maureen P.M.H Smeenk, Frank W.J.M Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study |
title | Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study |
title_full | Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study |
title_fullStr | Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study |
title_full_unstemmed | Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study |
title_short | Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study |
title_sort | care delivery pathways for chronic obstructive pulmonary disease in england and the netherlands: a comparative study |
topic | Policy Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440249/ https://www.ncbi.nlm.nih.gov/pubmed/22977431 |
work_keys_str_mv | AT utenscecilema caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy AT maarsejam caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy AT vanschayckonnocp caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy AT maesenboudewijnlp caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy AT ruttenmaureenpmh caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy AT smeenkfrankwjm caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy |